
1001 - 5000 employees
Founded 2011
💼 Consulting
📦 Logistics
🏭 Manufacturing
💰 $600M Debt Financing on 2022-08
Consulting • Logistics • Manufacturing
Celonis is a company that specializes in process mining and process intelligence, offering a platform to help enterprises improve their operational efficiency. With a suite of tools and solutions such as the process intelligence graph, process analysis, and process monitoring, Celonis enables businesses to gain insights into their processes, identify inefficiencies, and optimize workflows. The company's solutions cater to various industries, including finance, manufacturing, telecommunications, public sector, and more. Celonis is known for helping companies like PepsiCo and GE Healthcare achieve significant operational improvements and financial benefits by unlocking hidden value in their processes.
🕒 August 25
Improve your chances of getting an interview by checking your resume score before you apply.

1001 - 5000 employees
Founded 2011
💼 Consulting
📦 Logistics
🏭 Manufacturing
💰 $600M Debt Financing on 2022-08
Consulting • Logistics • Manufacturing
Celonis is a company that specializes in process mining and process intelligence, offering a platform to help enterprises improve their operational efficiency. With a suite of tools and solutions such as the process intelligence graph, process analysis, and process monitoring, Celonis enables businesses to gain insights into their processes, identify inefficiencies, and optimize workflows. The company's solutions cater to various industries, including finance, manufacturing, telecommunications, public sector, and more. Celonis is known for helping companies like PepsiCo and GE Healthcare achieve significant operational improvements and financial benefits by unlocking hidden value in their processes.
• Own the commercial relationship as the primary executive point of contact across the C-suite • Build relationships that extend beyond individual deal cycles and align Celonis with the customer’s long-term strategic agenda • Develop and execute expansion roadmaps identifying new business units, geographies, use cases, and platform capabilities • Drive ARR and NRR growth • Lead commercial negotiations for expansions, renewals, and multi-year enterprise agreements with Deal Desk and Legal • Translate adoption milestones and realized value into renewal confidence and expansion urgency with CVP and Value Engineering teams • Own forward-looking, commercially anchored executive business reviews • Position Celonis as a strategic platform within the customer’s operations and AI strategy • Connect Process Intelligence with LLM, automation, and agentic AI investments • Identify and mitigate commercial risks including sponsor departures, competitive displacement, implementation fatigue, and budget consolidation • Maintain multi-threaded executive relationships and documented value stories • Codify account strategies, expansion motions, and transformation navigation approaches into reusable assets • Maintain disciplined account plans, pipeline strategy, growth-target coverage, and forecast accuracy across a complex account set
• 12+ years in enterprise SaaS sales or strategic account management, including at least 5 years managing accounts with $5M+ ARR • Deep industry expertise in utilities • Preferred direct experience with AEP leading transformation initiatives or acting as a strategic consultant or Client Director • Demonstrated track record of growing ARR within named accounts over multi-year horizons • Executive presence and credibility at the C-suite level, including strategic conversations with CFOs, COOs, and CIOs • Experience navigating enterprise transformations such as ERP consolidations, cloud migrations, M&A, and organizational restructuring • Ability to construct business cases, including ROI modeling, TCO analysis, and value benchmarking • Comfort with long deal cycles and ambiguity; ability to manage stakeholders across 12–24+ month expansion arcs • Background in ERP, Supply Chain, Finance transformation, or AI-native enterprise platforms strongly preferred • Familiarity with agentic AI, automation, or intelligent process orchestration is a plus • Ability to work in a team-selling model with value engineering, professional services, partners, Growth, Industry, and Transformation teams • Visa sponsorship is not offered for this role
• Restricted Stock Units (RSUs) and merit-based refresh grants for every full-time Celonaut • Inclusive parental leave: 24 weeks of fully paid leave for primary carers and 12 weeks for supporting carers, available from the first day of employment • Unlimited PTO in applicable regions and generous PTO globally • Flexible hybrid work model balancing remote focus with office collaboration • 70-20-10 learning framework • Mentorship programs • Access to a dedicated learning platform • Subsidized Wellhub memberships • Mental health counseling • Dedicated Wellness Weeks • Paid time off for annual Impact Days to volunteer for community and environmental causes • Inclusion Think Tank and annual Inclusion Days
Apply Now🕒 August 25
Executive Director leading US payer access and pull-through strategies for BioCryst’s rare-disease therapeutics. Managing market access teams, accounts, launches, and reimbursement partnerships.
🇺🇸 United States – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
🕒 August 25
Director optimizing Syteline planning, scheduling, and SIOP for a multinational manufacturer. Balancing demand, supply, inventory, and production capacity for biotech products.
🕒 August 25
Development Director launching fundraising for Merit America's online college for working adults. Building donor pipelines, major gifts, and the advancement function for a new higher-education model.
🕒 August 25
Director guiding US payer access and value strategy for Summit Therapeutics’ investigational oncology immunotherapy. Communicating clinical and economic evidence to decision-makers and shaping formulary pathways.
🇺🇸 United States – Remote
💵 $190k - $237k / year
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
⏰ Full Time
🔴 Lead
👔 Director
🕒 August 25
Director advancing payer access for Summit Therapeutics’ investigational oncology immunotherapy, ivonescimab. Engaging US decision-makers with clinical, economic, and humanistic evidence.
🇺🇸 United States – Remote
💵 $190k - $237k / year
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
⏰ Full Time
🔴 Lead
👔 Director